# clm_A31B2D7AAD7A

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: research_and_development  
value: 3,051,100,000 United States dollar  
valid_from: 2021-12-31  
valid_to: null  
published: 2022-02-09  
recorded: 2026-11-08  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals research and development: 3,051,100,000 United States dollar", as of 2021-12-31. Claim clm_A31B2D7AAD7A, https://asof.is/claim/clm_A31B2D7AAD7A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532022000007/0000875320-22-000007-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2021, filed 2022-02-09  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532022000007/0000875320-22-000007-index.htm (primary, SEC EDGAR 10-K FY2021, published 2022-02-09)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | research_and_development | 1,829,537,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_A31B2D7AAD7A](/claim/clm_A31B2D7AAD7A.md) | [clm_4E727A17F6D8](/claim/clm_4E727A17F6D8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.